References
- De Doncker P, Gupta AD, Marynissen G. Itraconazole pulse therapy for onychomycosis in dermatomycoses: an overview. J Am Acad Dermatol 1997; 37: 969–974.
- Shemer A, Nathansohn N, Kaplan B, et al. Open randomized comparison of different itraconazole regimens for treatment of onychomycosis. J Dermatol Treat 1999; 10: 245–249.
- Willemsen M, De Doncker P, Willems J, et al. Post treatment itraconazole levels on the nail. J Am Acad Dermatol 1992; 26: 731–735.
- Cannenbergh G, Degreef H, Heykants J. Pharmacokinetic profile of orally administered itraconazole on human skin. J Am Acad Dermato11988; 18: 263–268.
- Leyden J. Pharmacokinetics and pharmacology of terbinafme and itraconazole. J Am Acad Dermato11998; 38 (Suppl. 1): s42—s47.
- Brautigam M. Terbinafme versus itraconazole: A controlled clinical comparison in onychomycosis of toenails. J Am Acad Dermato11998; 38 (Suppl. 1): s53—s56.
- Rousseuw D, De Doncker P. New approaches to the treatment of onychomycosis. J Am Acad Dermatol 1993; 29: 545–550.
- Evans EGV, Sigurgeirsson B. Doubled blind randomized study of continuous terbinafme compared with intermittent itracona-zole in treatment of toenail onychomycosis. BMJ 1999; 318: 1031–1035.
- Andre J, De Doncker P, Ginter G, et al. Intermittent pulse therapy with itraconazole in onychomycosis: an update. 54th Annual Meeting. American Academy of Dermatology, Washing-ton DC, 10–15 February 1996.